Resources
86 Results (showing 41 - 50)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 6/16/2020 (updated 3/28/2024)
The most effective therapy for people with opioid use disorder involves the use of Food and Drug Administration-approved medications—methadone, buprenorphine, and naltrexone. Despite evidence that this approach, known as medications for opioid use disorder, reduces relapse and saves lives, the vast majority of jails and prisons do not offer this treatment.
Posted 6/16/2020 (updated 3/28/2024)
This cross-sectional study included all counties and county-equivalent divisions in the US in 2016. Data on racial/ethnic population distribution were derived from the American Community Survey, and data on locations of facilities providing methadone and buprenorphine were obtained from Substance Abuse and Mental Health Services Administration databases.
Posted 6/30/2020 (updated 3/28/2024)
Representing 25 years of empirical study on addiction, pharmacology, behavioral health, and criminal justice, these Standards are the foundation upon which all adult drug courts must operate.
Posted 7/13/2020 (updated 3/28/2024)
The Facts About Buprenorphine for Treatment of Opioid Addiction is available in many languages, including Spanish.
Posted 11/21/2019 (updated 3/28/2024)
This guide provides a brief overview on identifying potential patients and introducing them to the program, as well as an overview of the medical-management counseling process.
Posted 12/30/2019 (updated 3/28/2024)
Pharmacotherapy of Opioid Use Disorder Webinar Presentation and Resources
Posted 12/30/2019 (updated 3/28/2024)
This analysis examines preliminary association of the program with overall overdose fatalities and deaths from overdose among those individuals who were recently incarcerated.
Posted 12/31/2019 (updated 3/28/2024)
To provide a procedure that both Nursing and Correctional Staff can adhere to for the orderly and secure issuance of suboxone.
Posted 1/24/2020 (updated 3/28/2024)
The FTC Best Practices Standards (BPS) provide local jurisdictions, states, tribes, and funders with clear practice guidance to improve outcomes for children, parents, and families affected by substance use and co-occurring disorders and involved with child welfare.
Posted 2/26/2020 (updated 3/28/2024)
In this cross-sectional study of data from 3142 US counties, counties in the South Atlantic, Mountain, and East North Central divisions had more than twice the odds of being at high risk for opioid overdose mortality and lacking in capacity to deliver medications for opioid use disorder. Higher density of primary care clinicians, a younger population, micropolitan status, and lower rates of unemployment were associated with lower risk of opioid overdose and lower risk of lacking in capacity to deliver medications for opioid use disorder.